The FDA just approved a new cancer treatment in an unconventional way: not by tumor type, but rather by the genetic mutation the drug targets. The drug, Vitrakvi, was developed by Loxo Oncology in partnership with pharma giant Bayer. It’s only the second time the FDA has approved a cancer drug’s use based on a […]
The work was published online in the Proceedings of the National Academy of Sciences. Phillip Cleves, PhD, a postdoctoral scholar at Stanford and coral enthusiast, is first author on the study. Cleves and his collaborators were able to use CRISPR to successfully introduce mutations to three genes (red fluorescent protein, green fluorescent protein and fibroblast […]
You probably know where your Social Security card, birth certificate and other sensitive information is being stored, but what about your genetic material? If you or your child was born in California after 1983, your DNA is likely being stored by the government, may be available to law enforcement and may even be in the […]
Our ability to sequence, synthesize, and edit DNA has advanced at a previously inconceivable speed. Far from being expensive and impractical, these DNA technologies are the most disruptive in all of biotechnology. It’s now possible to write custom DNA strands for pennies per base pair, at least for short strands. Two companies, GenScript Biotech Corp. […]